<SEC-DOCUMENT>0002007191-25-000071-index.html : 20251014
<SEC-HEADER>0002007191-25-000071.hdr.sgml : 20251014
<ACCEPTANCE-DATETIME>20251014083604
ACCESSION NUMBER:		0002007191-25-000071
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20251014
FILED AS OF DATE:		20251014
DATE AS OF CHANGE:		20251014

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Telix Pharmaceuticals Ltd
		CENTRAL INDEX KEY:			0002007191
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42128
		FILM NUMBER:		251389913

	BUSINESS ADDRESS:	
		STREET 1:		55 FLEMINGTON ROAD
		CITY:			NORTH MELBOURNE
		STATE:			C3
		ZIP:			3051
		BUSINESS PHONE:		61 3 9093 3855

	MAIL ADDRESS:	
		STREET 1:		55 FLEMINGTON ROAD
		CITY:			NORTH MELBOURNE
		STATE:			C3
		ZIP:			3051
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>q3results6k.htm
<DESCRIPTION>CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
<TEXT>
Document 1 - file: q3results6k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>prq3.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: prq3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>prq31.jpg
<TEXT>
Document 3 - file: prq31.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>prq32.jpg
<TEXT>
Document 4 - file: prq32.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>prq33.jpg
<TEXT>
Document 5 - file: prq33.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>prq34.jpg
<TEXT>
Document 6 - file: prq34.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>prq35.jpg
<TEXT>
Document 7 - file: prq35.jpg

</DOCUMENT>
</SEC-DOCUMENT>